Th1 Cells
Th1 Cells - Related Videos
08:39
An In Vivo Mouse Model to Measure Naïve CD4 T Cell Activation, Proliferation and Th1 Differentiation Induced by Bone Marrow-derived Dendritic Cells
0 Views •
Cited by 5 •
2018
Here, we present a protocol for the in vivo determination of naïve CD4 T cell (T cell) activation, proliferation, and Th1 differentiation induced by GM-CSF bone marrow (BM)-derived dendritic cells (DCs). In addition, this protocol describes BM and T-cell isolation, DC generation, and DC and T-cell adoptive transfer.
11:34
Murine Lymphocyte Labeling by 64Cu-Antibody Receptor Targeting for In Vivo Cell Trafficking by PET/CT
0 Views •
Cited by 3 •
2017
Following the preparation of a 64Cu-modified monoclonal antibody binding to a transgenic murine T cell receptor, T cells are radiolabeled in vivo, analyzed for viability, functionality, labeling stability and apoptosis, and adoptively transferred into mice with an airway delayed-type hypersensitivity reaction for non-invasive imaging by positron emission tomography/computed tomography (PET/CT).
03:28
Labeling Murine T Helper Lymphocytes using Radiolabeled Monoclonal Antibodies
0 Views •
2025
In this video, we demonstrate the intracellular radiolabeling of T helper cells using radioactive isotope-conjugated monoclonal antibodies for non-invasive positron emission tomography imaging.
10:04
Tractable In Vivo Reprogramming of Tumor Cells to Type 1 Conventional Dendritic Cell-like Cells
0 Views •
2025
This protocol describes the in vivo reprogramming of mouse cancer cells into type 1 dendritic-like cells within the tumor microenvironment through enforced expression of the transcription factors PU.1, IRF8, and BATF3.
09:29
Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
0 Views •
Cited by 10 •
2017
Here, we present a protocol to induce paralysis and opticospinal inflammation by transfer of aquaporin-4 (AQP4)-specific T cells from AQP4-/- mice into WT mice. In addition, we demonstrate how to use serial optical coherence tomography to monitor visual system dysfunction.
FAQs
Interleukin-12 supplies an activation signal after antigen presentation, while T-bet functions as the transcription factor that drives differentiation toward the Th1 program. This sequence links recognition of antigen to a specialized immune response rather than treating activation as a single event. The resulting cells are positioned to produce interferon-γ and coordinate downstream cellular defenses.
Interferon-γ provides a functional link between Th1-cell activity and cellular antimicrobial defense. It activates macrophages, strengthening the host response to intracellular pathogens, and it also supports cytotoxic immune functions. Because this cytokine sits downstream of differentiation, its production reflects how the Th1 program contributes to an effective cell-mediated response.
Their cytokine pathways help shape inflammatory responses, so Th1 activity can contribute to host defense while also becoming relevant to autoimmune disease. This connection explains why Th1 cells are studied in these conditions: they link cell-mediated immunity with inflammatory mechanisms examined in biology, medicine, and disease research.
Immune monitoring can focus on cytokine pathways associated with Th1 activity, especially the sequence connecting antigen presentation, interleukin-12, T-bet, and interferon-γ. Following this pathway helps researchers relate immune activation to cell-mediated defense and inflammatory responses. The approach is useful when studying host responses to infection or mechanisms relevant to autoimmune disease.
Vaccine design can use knowledge of Th1 cytokine pathways to consider how immunization might engage cell-mediated immunity. The interleukin-12, T-bet, and interferon-γ sequence provides a biological framework for connecting antigen-driven activation with macrophage responses and cytotoxic immune functions. This context helps researchers evaluate mechanisms that may support defense against intracellular pathogens.
Th1 biology identifies cytokine-linked steps that shape inflammation, including differentiation through T-bet and downstream interferon-γ production. Therapies that modulate inflammation can therefore be considered in relation to these pathways rather than as isolated immune events. This perspective is relevant to research on autoimmune disease, where inflammatory mechanisms are central to therapeutic investigation.